RAFAEL ALBERTO
LÓPEZ ZORZANO
Profesor contratado doctor
Publicaciones (119) Publicaciones de RAFAEL ALBERTO LÓPEZ ZORZANO
2023
-
Unleashing the potential of online learning in Spain: An econometric analysis
Telecommunications Policy, Vol. 47, Núm. 6
2021
-
Digital divides across consumers of internet services in Spain using panel data 2007-2019. Narrowing or not?
Documentos de Trabajo (ICAE)
-
Digital divides across consumers of internet services in Spain using panel data 2007–2019. Narrowing or not?
Telecommunications Policy, Vol. 45, Núm. 2
2020
-
Adoption of E-Commerce by Individuals and Digital-Divide
Applied Economics in the Digital Era: Essays in Honor of Gary Madden (Springer International Publishing), pp. 103-134
-
Consumer engagement in e-Tourism: Micro-panel data models for the case of Spain
Tourism Economics, Vol. 26, Núm. 6, pp. 853-872
-
Development of a multicriteria decision analysis framework for evaluating and positioning oncologic treatments in clinical practice
Journal of Oncology Practice
-
E-commerce by individuals in Spain using panel data 2008–2016
Telecommunications Policy, Vol. 44, Núm. 4
-
Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET
Colloids and Surfaces B: Biointerfaces, Vol. 188
-
Sphingomyelin-based nanosystems (SNs) for the development of anticancer miRNA therapeutics
Pharmaceutics, Vol. 12, Núm. 2
2019
-
Adoption of e-commerce by individuals and digital divide: Evidence from Spain
Documentos de Trabajo (ICAE)
-
Efficient evaluation of molecular electrostatic potential in large systems
Computation, Vol. 7, Núm. 4, pp. 1-19
-
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib
Annals of Oncology, Vol. 30, Núm. 12, pp. 1959-1968
-
Models for individual adoption of eCommerce, eBanking and eGovernment in Spain
Telecommunications Policy, Vol. 43, Núm. 1, pp. 100-111
-
Phase I/II trial to evaluate the efficacy and safety of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with pancreatic cancer and an ECOG performance status of 2
Journal of Clinical Oncology
2018
-
A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients
Targeted Oncology, Vol. 13, Núm. 1, pp. 69-78
-
Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients (Targeted Oncology, (2018), 13, 1, (69-78), 10.1007/s11523-017-0536-z)
Targeted Oncology
-
Drivers and barriers to cross-border e-commerce: Evidence from Spanish individual behavior
Telecommunications Policy, Vol. 42, Núm. 6, pp. 464-473
-
Efficient algorithm for expanding theoretical electron densities in canterakis–zernike functions
Journal of Computational Chemistry, Vol. 39, Núm. 24, pp. 2022-2032
-
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial
Breast Cancer Research and Treatment, Vol. 169, Núm. 3, pp. 469-479
-
Molecular modeling and physicochemical properties of 1-alkyl-3-methylimidazolium-FeX4 and -Fe2X7 (X = Cl and Br) magnetic ionic liquids
Journal of Molecular Liquids, Vol. 256, pp. 175-182